华南地区鲍曼不动杆菌流行株的毒力变迁研究

doi:10.3969/j.issn.1000-8535.2023.03.017

广州医药 ›› 2023, Vol. 54 ›› Issue (3): 91-96.DOI: 10.3969/j.issn.1000-8535.2023.03.017

华南地区鲍曼不动杆菌流行株的毒力变迁研究

唐翔¹, 曾军¹, 卓超², 杨智¹, 苏伟¹

1 广州市第一人民医院重症医学科(广州510180)
2 广州呼吸疾病健康研究院(广州 510120)

收稿日期:2022-09-01 出版日期:2023-03-20 发布日期:2023-04-14
通讯作者: 唐翔,E-mail:394828208@qq.com
基金资助:
广州市一般引导项目(20201A011011);广州市第一人民医院红棉计划(Q2019013)

The virulence of the prevalent clone ST457 of Acinetobacter baumannii in Southern China

TANG Xiang¹, ZENG Jun¹, ZHUO Chao², YANG Zhi¹, SU Wei¹

1 Intensive Care Unit, Guangzhou First People's Hospital, Guangzhou 510180, China
2 Guangzhou Institute of Respiratory Health, Guangzhou 510120, China

Received:2022-09-01 Online:2023-03-20 Published:2023-04-14

摘要/Abstract

摘要： 目的探讨我国南方地区鲍曼不动杆菌流行株ST457毒力进化方向。方法收集南方地区5家大型三甲医院2012年—2015年血和/或痰标本来源的鲍曼不动杆菌菌株,运用不同毒力实验,比较ST457与其他CC92流行克隆株与非流行克隆株的毒力差异。结果 ST457感染患者早期死亡率高;ST457菌株平均产生物膜能力低于ST195和ST208;83.3%的鲍曼不动杆菌临床分离菌株在血清的存活率大于60%,其中43.3%的菌株可在血清内快速繁殖,不同ST型组间、菌血症组和非菌血症组间无差异;不同ST型菌株竞争后,ST457未展现出竞争优势。结论与传统CC92流行株相比,ST457毒力表型与传统的CC92流行株类似,提示CC92克隆株共进化能力。部分流行株短时间内在血清中快速繁殖,提示其条件致病后潜在的血流感染的能力。

关键词: 鲍曼不动杆菌, ST457, 毒力

Abstract: Objective To investigate the virulence of the prevalent clone ST457 of Acinetobacter baumannii in Southern China. Methods Isolates from sputum and/or blood samples from 2012 to 2015 in 5 large differences between clonal complex 92(CC92) and non-CC92 were estimated by biofilm assay, competition assay and serum assay. Results Patients with ST457 infection had high early mortality. The average biofilm production of ST457 was significantly lower than that of ST195 and ST208. In serum assay, 83.3% isolates survived in the serum with over 60% survival rate, of which 43.3% strains reproduced in the serum, with no difference between STs or between bacteremia and non-bacteremia group. After competing with different ST strains, ST457 shows no competitive advantage. Conclusions ST457 had a similar virulence phenotype with the traditional prevalent CC92 clone, suggesting the co-evolutionary ability for CC92 clone. Some clinical isolates were survived in human serum, suggesting the potential capacity of bloodstream infection.

Key words: Acinetobacter baumannii, ST457, virulence

唐翔, 曾军, 卓超, 杨智, 苏伟. 华南地区鲍曼不动杆菌流行株的毒力变迁研究[J]. 广州医药, 2023, 54(3): 91-96.

TANG Xiang, ZENG Jun, ZHUO Chao, YANG Zhi, SU Wei. The virulence of the prevalent clone ST457 of Acinetobacter baumannii in Southern China[J]. Guangzhou Medical Journal, 2023, 54(3): 91-96.

参考文献

[1] de OLIVEIRA D M P,FORDE B M,KIDD T J,et al. Antimicrobial Resistance in ESKAPE Pathogens[J]. Clin Microbiol Rev, 2020,33(3):e00181-19.
[2] Antimicrobial Resistance Collaborators. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis[J]. Lancet,2022, 399(10325):629-655.
[3] CDC. Antibiotic Resistance Threats in the United States, 2019[R]. Atlanta, GA: U.S. Department of Health and Human Services, 2019.
[4] GU Y, ZHANG W, LEI J, et al. Molecular epidemiology and carbapenem resistance characteristics of Acinetobacter baumannii causing bloodstream infection from 2009 to 2018 in northwest China[J]. Front Microbiol,2022(13):983963.
[5] KARAH N, SUNDSFJORD A, TOWNER K, et al. Insights into the global molecular epidemiology of carbapenem non-susceptible clones of Acinetobacter baumannii[J]. Drug Resist Updat,2012,15(4):237-247.
[6] JIANG M, LIU L, MA Y, et al. Molecular epidemiology of multi-Drug resistant acinetobacter baumannii isolated in Shandong, China [J]. Front Microbiol, 2016(7):1687.
[7] YING J, LU J, ZONG L, et al. Molecular epidemiology and characterization of genotypes of acinetobacter baumannii isolates from regions of south china [J]. Jpn J Infect Dis, 2016, 69(3): 180-185.
[8] NING N Z, LIU X, BAO C M, et al. Molecular epidemiology of bla OXA-23 -producing carbapenem-resistant Acinetobacter baumannii in a single institution over a 65-month period in north China [J]. BMC Infect Dis, 2017, 17(1): 14.
[9] CHENG V C, CHEN J H, POON R W, et al. Control of hospital endemicity of multiple-drug-resistant Acinetobacter baumannii ST457 with directly observed hand hygiene[J]. Eur J Clin Microbiol Infect Dis,2015, 34(4):713-718.
[10] WEN H, WANG K, LIU Y, et al. Population dynamics of an Acinetobacter baumannii clonal complex during colonization of patients [J]. J Clin Microbiol, 2014, 52(9): 3200-3208.
[11] HUANG G, YIN S, XIANG L, et al. Epidemiological characterization of Acinetobacter baumannii bloodstream isolates from a Chinese Burn Institute: A three-year study [J]. Burns,2016,42(7):1542-1547.
[12] K ZHOU, TANG X , WANG L , et al. An Emerging Clone (ST457) of Acinetobacter baumannii Clonal Complex 92 With Enhanced Virulence and Increasing Endemicity in South China[J]. Clin Infect Dis, 2018(suppl_2):S179-S188.
[13] MEA H J , YONG P , WONG E H . An overview of Acinetobacter baumannii pathogenesis: motility, adherence and biofilm formation[J]. Microbiol Res, 2021(1):126722.
[14] NEMEC A, KRIZOVA L, MAIXNEROVA M, et al. Acinetobacter seifertii sp. nov., a member of the Acinetobacter calcoaceticus-Acinetobacter baumannii complex isolated from human clinical specimens [J]. Int J Syst Evol Microbiol, 2015, 65(Pt 3): 934-942.
[15] MARCHAIM D, LEVIT D, ZIGRON R, et al. Clinical and molecular epidemiology of Acinetobacter baumannii bloodstream infections in an endemic setting [J]. Future Microbiol, 2016, 12(4): 271-283.
[16] HARDING C M, HENNON S W, FELDMAN M F. Uncovering the mechanisms of Acinetobacter baumannii virulence [J]. Nat Rev Microbiol,2018,16(2):91-102.
[17] HARDING C M, PULIDO M R, DI VENANZIO G, et al. AcinetobacterPathogenic species have a functional type I secretion system and contact-dependent inhibition systems[J]. J Biol Chem, 2017, 292(22): 9075-9087.
[18] BARDBARI AM, ARABESTANI M, REZA KM, et al. Correlation between ability of biofilm formation with their responsible genes and MDR patterns in clinical and environmental Acinetobacter baumannii isolates[J]. Microb Pathog, 2017(108): 122-128.
[19] EIJKELKAMP B A,HASSAN K A,PAULSEN I T,et al. Investigation of the human pathogen Acinetobacter baumannii under iron limiting conditions[J]. BMC Genomics, 2011, (12): 126.
[20] PAKHARUKOVA N, TUITTILA M, PAAVILAINEN S, et al. Structural basis for Acinetobacter baumannii biofilm formation[J]. Proc Natl Acad Sci U S A,2018,115(21):5558-5563.
[21] de BREIJ A, GADDY J, van der MEER J,et al. CsuA/BABCDE-dependent pili are not involved in the adherence of Acinetobacter baumannii ATCC19606(T) to human airway epithelial cells and their inflammatory response[J]. Res Microbiol,2009,160(3):213-218.
[22] ROSALES-REYES R, GAYOSSO-VAZQUEZ C, FERNANDEZ-VAZQUEZ J L, et al. Virulence profiles and innate immune responses against highly lethal, multidrug-resistant nosocomial isolates of Acinetobacter baumannii from a tertiary care hospital in Mexico [J]. PLoS One, 2017, 12(8): e0182899.
[23] SANCHEZ-LARRAYOZ A F, ELHOSSEINY N M, CHEVRETTE M G, et al. Complexity of Complement Resistance Factors Expressed by Acinetobacter baumannii Needed for Survival in Human Serum [J]. J Immunol, 2017, 199(8): 2803-2814.
[24] BOLOURCHI N , SHAHCHERAGHI F ,SHIRAZI A S,et al. Immunogenic reactivity of recombinant PKF and AbOmpA proteins as serum resistance factors against sepsis of Acinetobacter baumannii[J]. Microb Pathog, 2019(131): 9-14.
[25] RUSSO T A, LUKE N R, BEANAN J M, et al. The K1 capsular polysaccharide of Acinetobacter baumannii strain 307-0294 is a major virulence factor [J]. Infect Immun, 2010, 78(9): 3993-4000.
[26] LEES-MILLER R G, IWASHKIW J A, SCOTT N E, et al. A common pathway for O-linked protein-glycosylation and synthesis of capsule in Acinetobacter baumannii [J]. Mol Microbiol, 2013, 89(5): 816-830.
[27] OU H Y, KUANG S N, HE X, et al. Complete genome sequence of hypervirulent and outbreak-associated Acinetobacter baumannii strain LAC-4: epidemiology, resistance genetic determinants and potential virulence factors[J]. Sci Rep,2015(5): 8643.

华南地区鲍曼不动杆菌流行株的毒力变迁研究

The virulence of the prevalent clone ST457 of Acinetobacter baumannii in Southern China

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 2

编辑推荐

Metrics

本文评价

[1]	郭伟鸿, 潘楚芝, 黄慕超, 方昌全, 郭鹏豪, 陈惠玲, 赵子文, 李裕军. 广州地区鲍曼不动杆菌的多位点序列分型及流行克隆[J]. 广州医药, 2022, 53(1): 20-25.
[2]	梁慧玲, 韩超, 郑琳颖, 张秋玲, 刘道利, 周伟青. 翘芩清肺剂中药免煎颗粒剂与饮片剂的抑菌作用比较[J]. 广州医药, 2021, 52(3): 112-116.